Welcome to
Scandinavian Biopharma

Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, immunoglobulin’s, biodefense, antidotes and diagnostic tests.

Research and development is mainly focused on development of a new oral traveler’s diarrhea vaccine in collaboration with PATH Vaccine Solutions and University of Gothenburg.


We are proud to be “2018 Distributor of the year”

2018-09-27

Standing out from keen competitions, we are very proud to announce that we were the winner of the “2018 Distributor of the Year” award at AJ Vaccines Summit last week. The award was given to us for “Effectively having ensured a successful market presence of AJ Vaccines TdaP vaccine within a highly competitive market, an in […]

Sweden’s ambassador Annika Thunborg attended the VASE conference in Mexico City

2018-07-05

VASE 2018 (2nd International Vaccines Against Shigella and ETEC) in Mexico City gathered scientists, public health professionals, immunization leaders, vaccine industry representatives, international donors, and other experts around the globe to share research and ideas toward making Shigella and enterotoxigenic Escherichia coli (ETEC) vaccines a reality. On-site was also Sweden’s ambassador in Mexico, Annika Thunborg. During the meeting the Ambassador presented Sweden’s strategy […]

We want to raise awareness

2018-06-14

We at Scandinavian Biopharma are very proud to be an active participant in the endeavor to reduce child mortality and morbidity. We want to raise awareness of the leading causes of diarrhea and we are doing everything we can to develop a vaccine that will improve children’s chances of winning the fight against diarrheal disease. […]